105 related articles for article (PubMed ID: 23945523)
1. Release of N-acetylcysteine and N-acetylcysteine amide from contact lenses.
Atabek Yigit E; Ercal N
Eye Contact Lens; 2013 Sep; 39(5):335-40. PubMed ID: 23945523
[TBL] [Abstract][Full Text] [Related]
2. Antioxidant and free radical scavenging properties of N-acetylcysteine amide (NACA) and comparison with N-acetylcysteine (NAC).
Ates B; Abraham L; Ercal N
Free Radic Res; 2008 Apr; 42(4):372-7. PubMed ID: 18404536
[TBL] [Abstract][Full Text] [Related]
3. N-Acetylcysteine amide: a derivative to fulfill the promises of N-Acetylcysteine.
Sunitha K; Hemshekhar M; Thushara RM; Santhosh MS; Yariswamy M; Kemparaju K; Girish KS
Free Radic Res; 2013 May; 47(5):357-67. PubMed ID: 23472882
[TBL] [Abstract][Full Text] [Related]
4. Quantitation of free and total N-acetylcysteine amide and its metabolite N-acetylcysteine in human plasma using derivatization and electrospray LC-MS/MS.
King B; Vance J; Wall GM; Shoup R
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Mar; 1109():25-36. PubMed ID: 30708342
[TBL] [Abstract][Full Text] [Related]
5. N-Acetylcysteine amide (NACA) and diNACA inhibit H
Martis RM; Grey AC; Wu H; Wall GM; Donaldson PJ; Lim JC
Exp Eye Res; 2023 Sep; 234():109610. PubMed ID: 37536438
[TBL] [Abstract][Full Text] [Related]
6. Characterizing N-acetylcysteine (NAC) and N-acetylcysteine amide (NACA) binding for lead poisoning treatment.
Chen W; Ercal N; Huynh T; Volkov A; Chusuei CC
J Colloid Interface Sci; 2012 Apr; 371(1):144-9. PubMed ID: 22284448
[TBL] [Abstract][Full Text] [Related]
7. In vivo inhibition of l-buthionine-(S,R)-sulfoximine-induced cataracts by a novel antioxidant, N-acetylcysteine amide.
Carey JW; Pinarci EY; Penugonda S; Karacal H; Ercal N
Free Radic Biol Med; 2011 Mar; 50(6):722-9. PubMed ID: 21172425
[TBL] [Abstract][Full Text] [Related]
8. Effects of N-acetylcysteine amide (NACA), a thiol antioxidant on radiation-induced cytotoxicity in Chinese hamster ovary cells.
Wu W; Abraham L; Ogony J; Matthews R; Goldstein G; Ercal N
Life Sci; 2008 May; 82(21-22):1122-30. PubMed ID: 18448127
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic profile of N-acetylcysteine amide and its main metabolite in mice using new analytical method.
He R; Zheng W; Ginman T; Ottosson H; Norgren S; Zhao Y; Hassan M
Eur J Pharm Sci; 2020 Feb; 143():105158. PubMed ID: 31740394
[TBL] [Abstract][Full Text] [Related]
10. Effects of N-acetylcysteine amide (NACA), a novel thiol antioxidant against glutamate-induced cytotoxicity in neuronal cell line PC12.
Penugonda S; Mare S; Goldstein G; Banks WA; Ercal N
Brain Res; 2005 Sep; 1056(2):132-8. PubMed ID: 16120436
[TBL] [Abstract][Full Text] [Related]
11. Effects of N-Acetylcysteine and N-Acetylcysteine Amide on Erythrocyte Deformability and Oxidative Stress in a Rat Model of Lower Extremity Ischemia-Reperfusion Injury.
Erol G; Kartal H; Comu FM; Cetin E; Demirdas E; Sicim H; Unal CS; Gunay C; Oz BS; Bolcal C
Cardiol Res Pract; 2020; 2020():6841835. PubMed ID: 33062321
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effects of N-acetylcysteine amide on experimental focal penetrating brain injury in rats.
Günther M; Davidsson J; Plantman S; Norgren S; Mathiesen T; Risling M
J Clin Neurosci; 2015 Sep; 22(9):1477-83. PubMed ID: 26100161
[TBL] [Abstract][Full Text] [Related]
13. Systematic Review of Human and Animal Studies Examining the Efficacy and Safety of
Bhatti J; Nascimento B; Akhtar U; Rhind SG; Tien H; Nathens A; da Luz LT
Front Neurol; 2017; 8():744. PubMed ID: 29387038
[TBL] [Abstract][Full Text] [Related]
14. In vitro drug release and in vivo safety of vitamin E and cysteamine loaded contact lenses.
Dixon P; Fentzke RC; Bhattacharya A; Konar A; Hazra S; Chauhan A
Int J Pharm; 2018 Jun; 544(2):380-391. PubMed ID: 29217475
[TBL] [Abstract][Full Text] [Related]
15. Temperature sensitive contact lenses for triggered ophthalmic drug delivery.
Jung HJ; Chauhan A
Biomaterials; 2012 Mar; 33(7):2289-300. PubMed ID: 22182750
[TBL] [Abstract][Full Text] [Related]
16. Drug delivery by contact lens in spontaneously glaucomatous dogs.
Peng CC; Ben-Shlomo A; Mackay EO; Plummer CE; Chauhan A
Curr Eye Res; 2012 Mar; 37(3):204-11. PubMed ID: 22335807
[TBL] [Abstract][Full Text] [Related]
17. Recovery of the water content of hydrogel contact lenses after use.
Cabrera JV; Velasco MJ
Ophthalmic Physiol Opt; 2005 Sep; 25(5):452-7. PubMed ID: 16101953
[TBL] [Abstract][Full Text] [Related]
18. In vitro analysis of a novel controlled release system designed for intratympanic administration of N-acetylcysteine: a preliminary report.
Ciftci Z; Deniz M; Yilmaz I; Ciftci HG; Sirin DY; Gultekin E
Am J Otolaryngol; 2015; 36(6):786-93. PubMed ID: 26545472
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of N-acetylcysteine after oral and intravenous administration to healthy cats.
Buur JL; Diniz PP; Roderick KV; KuKanich B; Tegzes JH
Am J Vet Res; 2013 Feb; 74(2):290-3. PubMed ID: 23363356
[TBL] [Abstract][Full Text] [Related]
20. Extended Ciprofloxacin Release Using Vitamin E Diffusion Barrier From Commercial Silicone-Based Soft Contact Lenses.
Shayani Rad M; Mohajeri SA
Eye Contact Lens; 2017 Mar; 43(2):103-109. PubMed ID: 26863046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
